Disney/Marvel’s Doctor Strange passed into the $600M+ dimension this weekend with a total $616M worldwide through Sunday. This was the 5th offshore frame for the Sorcerer Supreme and added $9.8M at the international box office ($410.9M cume to date), plus $13.4M for the domestic 3-day ($205.1M cume to date). That thrusts the Benedict Cumberbatch-starrer into the Top 10 of 2016 domestically, overseas and globally. The film has also now become the biggest single-character introduction in the Marvel Cinematic Universe.

In further milestones, the Scott Derrickson-directed pic is the 9th MCU title to cross the $600M mark, and Disney’s 5th 2016 movie to do so. Japan, meanwhile, is still to come with a January 27 release.

Earlier this month, Disney reached $6B in global box office, a first for the studio and aided by the spellbinding Stephen Strange.

Compared to his stable mates, Doctor Strange has now surpassed the worldwide lifetime cumes of The Incredible Hulk ($263M), Captain America: The First Avenger ($371M), Thor ($449M), Ant-Man ($520M) and Iron Man ($585M).

Domestically, the surgeon has levitated over the lifetimes of The Incredible Hulk ($135M), Cap 1 ($177M), Ant-Man ($180M) and Thor ($181M). It’s about to also pass Thor: The Dark World ($206.4M).

Internationally, the film is bigger than The Incredible Hulk ($129M), Cap 1 ($194M), Iron Man ($266M), Thor ($268M), Iron Man 2 ($310M) and Ant-Man ($339M). Doctor Strange has also surpassed the lifetime cume of 2016’s X-Men: Apocalypse at all three levels ($155M/$388M/$544M).

He’s been particularly handsy in Asia with China as the No. 1 market at $109.6M, followed by Korea at $40.9M. The UK ($27.5M), Russia ($21.9M) and Brazil ($20.9M) round out the Top 5.

This session’s only new opening was Argentina with a $1M No. 1 start ahead of a national holiday tomorrow.